These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 16263233

  • 1. Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Dec; 53(4):329-32. PubMed ID: 16263233
    [Abstract] [Full Text] [Related]

  • 2. Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
    Sader HS, Watters AA, Fritsche TR, Jones RN.
    BMC Infect Dis; 2007 Apr 18; 7():29. PubMed ID: 17442104
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
    Pfaller MA, Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2007 Apr 18; 57(4):459-65. PubMed ID: 17240105
    [Abstract] [Full Text] [Related]

  • 4. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
    Sader HS, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Oct 18; 65(2):158-62. PubMed ID: 19748426
    [Abstract] [Full Text] [Related]

  • 5. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug 18; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 6. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
    Sader HS, Streit JM, Fritsche TR, Jones RN.
    Clin Microbiol Infect; 2006 Sep 18; 12(9):844-52. PubMed ID: 16882289
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
    Sader HS, Streit JM, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2004 Nov 18; 50(3):201-4. PubMed ID: 15541606
    [Abstract] [Full Text] [Related]

  • 8. Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).
    Castanheira M, Jones RN, Sader HS.
    Diagn Microbiol Infect Dis; 2008 Jun 18; 61(2):235-9. PubMed ID: 18314293
    [Abstract] [Full Text] [Related]

  • 9. LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
    Jones RN, Fritsche TR, Sader HS, Ross JE.
    Diagn Microbiol Infect Dis; 2007 Nov 18; 59(3):309-17. PubMed ID: 17720350
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility of daptomycin and comparator agents tested against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: trend analysis of a 6-year period in US medical centers (2005-2010).
    Sader HS, Moet GJ, Farrell DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2011 Jul 18; 70(3):412-6. PubMed ID: 21546202
    [Abstract] [Full Text] [Related]

  • 11. Daptomycin in vitro susceptibility in European Gram-positive clinical isolates.
    Fluit AC, Schmitz FJ, Verhoef J, Milatovic D.
    Int J Antimicrob Agents; 2004 Jul 18; 24(1):59-66. PubMed ID: 15225863
    [Abstract] [Full Text] [Related]

  • 12. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS, Fritsche TR, Jones RN.
    Diagn Microbiol Infect Dis; 2005 Jul 18; 52(3):265-73. PubMed ID: 16105569
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial activity of daptomycin tested against Staphylococcus aureus with vancomycin MIC of 2 microg/mL isolated in the United States and European hospitals (2006-2008).
    Sader HS, Becker HK, Moet GJ, Jones RN.
    Diagn Microbiol Infect Dis; 2010 Mar 18; 66(3):329-31. PubMed ID: 20159377
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
    Fritsche TR, Sader HS, Stillwell MG, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Apr 18; 63(4):440-6. PubMed ID: 19302928
    [Abstract] [Full Text] [Related]

  • 15. [Comparative in vitro activity of daptomycin against gram-positive microorganisms: SENTRY surveillance program, Spain (2002-2006)].
    Loza E, Morosini MI, Pascual A, Tubau F, Alcalá J, Liñares J, Hernández-Bello JR, Baquero F, Perea E, Martín R, Jones RN, Cantón R, SENTRY Surveillance Program, Spain (2002-2006).
    Enferm Infecc Microbiol Clin; 2008 Oct 18; 26(8):489-94. PubMed ID: 19094861
    [Abstract] [Full Text] [Related]

  • 16. Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.
    Biedenbach DJ, Jones RN.
    Diagn Microbiol Infect Dis; 2009 Jun 18; 64(2):202-12. PubMed ID: 19321284
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of daptomycin against Gram-positive cocci: the first multicentre study in Greece.
    Malli E, Spiliopoulou I, Kolonitsiou F, Klapsa D, Giannitsioti E, Pantelidi K, Pratti A, Panopoulou M, Grapsa S, Alepopoulou E, Neonakis I, Frantzidou F, Alexiou-Daniel S, Bakola D, Koutsia-Carouzou C, Malamou-Lada H, Zerva L, Vlahaki E, Kartali-Ktenidou S, Anastassiou ED, Petinaki E.
    Int J Antimicrob Agents; 2008 Dec 18; 32(6):525-8. PubMed ID: 18774268
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial activity of daptomycin tested against gram-positive strains collected in European hospitals: results from 7 years of resistance surveillance (2003-2009).
    Sader HS, Farrell DJ, Jones RN.
    J Chemother; 2011 Aug 18; 23(4):200-6. PubMed ID: 21803696
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of daptomycin against isolates of Staphylococcus aureus and enterococci: first results from Turkey.
    Arslan H, Azap OK, Ergin F, Karaman SO, Oruç E.
    Int J Antimicrob Agents; 2004 Jun 18; 23(6):642-3. PubMed ID: 15194140
    [No Abstract] [Full Text] [Related]

  • 20. Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients.
    Sader HS, Fritsche TR, Jones RN.
    Int J Infect Dis; 2009 Mar 18; 13(2):291-5. PubMed ID: 18938097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.